{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:45:24Z","timestamp":1789573524499,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-HL-007849"],"award-info":[{"award-number":["T32-HL-007849"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsthoracicsurgery.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Annals of Thoracic Surgery"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.athoracsur.2019.11.011","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T11:06:51Z","timestamp":1577444811000},"page":"492-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cost-Effectiveness of Postoperative Drug Rehabilitation for Injection Drug Users"],"prefix":"10.1016","volume":"110","author":[{"given":"Zachary","family":"Tyerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Hunter","family":"Mehaffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Wanchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T.","family":"Rogawski McQuade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorav","family":"Ailawadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenan W.","family":"Yount","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.athoracsur.2019.11.011_bib1","doi-asserted-by":"crossref","first-page":"k496","DOI":"10.1136\/bmj.k496","article-title":"Failing health of the United States","volume":"360","author":"Woolf","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc1204141","article-title":"Effect of abuse-deterrent formulation of OxyContin","volume":"367","author":"Cicero","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib5","first-page":"719","article-title":"Vital signs: demographic and substance use trends among heroin users-United States, 2002-2013","volume":"64","author":"Jones","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV infection linked to injection use of oxymorphone in Indiana, 2014-2015","volume":"375","author":"Peters","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129360","article-title":"A\u00a0cost analysis of hospitalizations for infections related to injection drug use at a county safety-net hospital in Miami, Florida","volume":"10","author":"Tookes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1749-8090-9-58","article-title":"Surgical treatment of infective endocarditis in active intravenous drug users: a justified procedure?","volume":"9","author":"Weymann","year":"2014","journal-title":"J\u00a0Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.15585\/mmwr.mm6622a1","article-title":"Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence-North Carolina, 2010-2015","volume":"66","author":"Fleischauer","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijcard.2015.03.368","article-title":"Current profile of infective endocarditis in intravenous drug users: the prognostic relevance of the valves involved","volume":"187","author":"Ortiz-Bautista","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/icvts\/ivv397","article-title":"Cardiac surgery for infective endocarditis in patients with intravenous drug use","volume":"22","author":"Osterdal","year":"2016","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0002-9343(79)90447-9","article-title":"Recurrent infective endocarditis: analysis of predisposing factors and clinical features","volume":"66","author":"Welton","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.amjmed.2015.09.024","article-title":"Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis","volume":"129","author":"Rosenthal","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1360-0443.2007.01764.x","article-title":"The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City","volume":"102","author":"Des Jarlais","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib17","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/aje\/kwu345","article-title":"Modeling the initiation of others into injection drug use, using data from 2,500 injectors surveyed in Scotland during 2008-2009","volume":"181","author":"White","year":"2015","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib18","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","article-title":"Recommendations of the Panel on Cost-effectiveness in Health and Medicine","volume":"276","author":"Weinstein","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib20","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.athoracsur.2015.03.019","article-title":"Injection drug use and outcomes after surgical intervention for infective endocarditis","volume":"100","author":"Shrestha","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib21","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/S2468-2667(17)30006-3","article-title":"Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study","volume":"2","author":"Uyei","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/QAI.0000000000000768","article-title":"Impact of illicit drug use on health-related quality of life in opioid-dependent patients undergoing HIV treatment","volume":"70","author":"Aden","year":"2015","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0740-5472(03)00130-2","article-title":"Overview of 5-year followup outcomes in the Drug Abuse Treatment Outcome Studies (DATOS)","volume":"25","author":"Hubbard","year":"2003","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib25","first-page":"615","article-title":"Cost-effectiveness of inpatient substance abuse treatment","volume":"32","author":"Barnett","year":"1997","journal-title":"Health Serv Res"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jsat.2017.04.016","article-title":"Relapse to opioid use disorder after inpatient treatment: protective effect of injection naltrexone","volume":"85","author":"Nunes","year":"2018","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib27","first-page":"271","article-title":"Residential addiction treatment for injection drug users requiring intravenous antibiotics: a cost-reduction strategy","volume":"7","author":"Jewell","year":"2013","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001825","article-title":"An unsupported preference for intravenous antibiotics","volume":"12","author":"Li","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1540-8191.1990.tb00738.x","article-title":"Surgical management of endocarditis in drug addicts and long-term results","volume":"5","author":"Frater","year":"1990","journal-title":"J\u00a0Card Surg"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.athoracsur.2011.08.016","article-title":"Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users","volume":"93","author":"Rabkin","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(96)02536-6","article-title":"HIV incidence among injecting drug users in New York City syringe-exchange programmes","volume":"348","author":"Des Jarlais","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib33","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0140-6736(96)11380-5","article-title":"Effectiveness of needle-exchange programmes for prevention of HIV infection","volume":"349","author":"Hurley","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib34","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1007\/s10461-014-0789-9","article-title":"Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment","volume":"18","author":"Nguyen","year":"2014","journal-title":"AIDS Behav"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/14737167.8.2.165","article-title":"Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold","volume":"8","author":"Grosse","year":"2008","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.athoracsur.2019.11.011_bib36","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness\u2014the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N\u00a0Engl J Med"}],"container-title":["The Annals of Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497519319241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497519319241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T04:05:37Z","timestamp":1757736337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003497519319241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0003497519319241"],"URL":"https:\/\/doi.org\/10.1016\/j.athoracsur.2019.11.011","relation":{},"ISSN":["0003-4975"],"issn-type":[{"value":"0003-4975","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Postoperative Drug Rehabilitation for Injection Drug Users","name":"articletitle","label":"Article Title"},{"value":"The Annals of Thoracic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athoracsur.2019.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The Society of Thoracic Surgeons Published by Elsevier","name":"copyright","label":"Copyright"}]}}